|
Volumn 4, Issue 3, 2008, Pages 156-163
|
A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium
a a a a a a a a a a a a a a a a a a a a more..
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
ALZHEIMER DISEASE VACCINE;
AMYLOID BETA PROTEIN;
ANALGESIC AGENT;
APOLIPOPROTEIN E4;
CHOLINESTERASE;
CHOLINESTERASE INHIBITOR;
GINKGO BILOBA EXTRACT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
PLACEBO;
ROFECOXIB;
ROSIGLITAZONE;
TAU PROTEIN;
ALZHEIMER DISEASE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CULTURAL FACTOR;
DEMENTIA;
DISEASE COURSE;
DISEASE MARKER;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
EARLY DIAGNOSIS;
ECONOMIC ASPECT;
EXCITOTOXICITY;
GENETIC RISK;
HUMAN;
IMMUNOTHERAPY;
LIFESTYLE MODIFICATION;
NERVE CELL NECROSIS;
NERVE DEGENERATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OXIDATIVE STRESS;
PATHOGENESIS;
PHARMACOGENOMICS;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK FACTOR;
SOCIAL ASPECT;
SYMPOSIUM;
CLINICAL TRIALS AS TOPIC;
DEMENTIA;
DRUG DESIGN;
HUMANS;
|
EID: 43649096329
PISSN: 15525260
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jalz.2008.03.005 Document Type: Review |
Times cited : (43)
|
References (0)
|